Sonnet BioTherapeutics Inc. (SONN) Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Sonnet BioTherapeutics Inc. (SONN)'s estimated annual revenue is currently $1.7M per year.(i)
  • Sonnet BioTherapeutics Inc. (SONN)'s estimated revenue per employee is $154,545

Employee Data

  • Sonnet BioTherapeutics Inc. (SONN) has 11 Employees.(i)

Sonnet BioTherapeutics Inc. (SONN)'s People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
VP, Business DevelopmentReveal Email/Phone
3
Chief Scientific Officer & Co-FounderReveal Email/Phone
4
Chief Technical OfficerReveal Email/Phone

What Is Sonnet BioTherapeutics Inc. (SONN)?

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sonnet BioTherapeutics Inc. (SONN) News

2022-04-06 - Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research (AACR) 2022 Annual Meeting

PRINCETON, NJ / ACCESSWIRE / April 8, 2022/ Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing...

2022-04-06 - Sonnet BioTherapeutics Announces First Patient Dosed in ...

PRINCETON, NJ / ACCESSWIRE / April 13, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing...

2022-04-06 - Do Traders Think Sonnet BioTherapeutics Holdings, Inc. (SONN) Can Keep Climbing Wednesday?

(SONN) stock is up 12.82% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator. Sentiment Score - ,bullish.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M110%N/A
#2
$0.4M110%$21.5M
#3
$1M110%N/A
#4
$1M11N/AN/A
#5
$1M11N/AN/A